-
'Trying to bury the science': US climate research under siege
-
Skies darken as solar eclipse heads south from Arctic to Spain
-
Eurovision to bar countries at war from hosting
-
Protest denounces secrecy of Venezuela transition talks
-
Italian teenager Curtis breaks 50m backstroke world record at Europeans
-
NBA's Los Angeles Lakers to be sold for reported $12.5 bn
-
New mum Sjostrom wins 50m butterfly for 18th European gold
-
Lukaku joins Turkish side Fenerbahce from Napoli
-
Solar eclipse darkens Arctic Russia on course for Spain
-
Colombia quake rescue efforts enter 'final phase' as toll hits 239
-
Russian economy rebounds in second quarter despite Ukrainian strikes
-
Brazil orders suspension of Discord livestreams after teen suicide
-
NBA's Los Angeles Lakers to be sold for $12.5 bn: ESPN
-
Tourists rush to Mount Etna as Italian volcano erupts
-
Trump sued over sale of access to Truth Social posts
-
Knot and Venmo Team Up to Make Venmo the Effortless Way to Pay
-
Europe looks to the skies as solar eclipse cast its shadow
-
In Moscow, Russians worry about new fuel shortages
-
At least 44 drown after ferry overturns on Zimbabwe's Lake Kariba
-
New space object 'black hole star' discovered by astronomers
-
Grieving Argentine icon Messi unsure about playing on 'much longer'
-
England captain Root tells players to be 'adults' as he ditches curfew
-
Nigeria kidnap victims escape 'hellfire' captivity beaten, malnourished
-
US inflation slows slightly in July despite elevated fuel prices
-
Google unveils finder tag, new AI smartphone features
-
Total solar eclipse to cast its shadow over Europe
-
US equities gain as inflation report eases fear of rate rise
-
US consumer inflation slows slightly in July despite elevated fuel prices
-
Colombia declares three days mourning for quake victims
-
Warholm on track in bid for fourth Euro hurdles gold
-
44 lives lost after ferry capsizes on Zimbabwe's Lake Kariba
-
Erdogan eyes expansion of regional defence pact
-
WallStreetPR Releases Report on China’s Gold Purchases and African Mining Investment
-
Extreme weather, jellyfish knock one-fifth of France's nuclear capacity offline
-
Former Chinese premier Zhu Rongji dies aged 97
-
Skywatchers gather in Europe to see total solar eclipse
-
Markets steady awaiting US inflation data
-
Zhu Rongji, trailblazing ex-premier who transformed China's economy
-
WHO says Trump vaccine shake-up goes against evidence
-
China tech giant Tencent's Q2 profit down as AI push builds
-
Eclipse chasers flock to Spain for 'breathtaking' experience
-
China's C919 jet makes first international commercial flight
-
'To make the civilians leave': Russia pummels Ukraine's petrol stations
-
Mideast war impact on travel bookings fading, TUI says
-
Japan brushes off Australian PM's melon drama
-
Bangladesh get Das fitness boost for daunting Australia task
-
Rod Stewart cancels tour dates after heart surgery
-
One dead, 172 rescued as second ferry in days catches fire in Indonesia
-
How Britain's mapmakers track climate change
-
Foxconn posts quarterly profit surge on AI server demand
Dogs die as South Africa snake antivenom shortage bites
Zarza, a much-loved Staffordshire terrier, ended up at a South African animal hospital with a bite from a Mozambique spitting cobra on her snout.
The snake's powerful venom can stop the breathing muscles from working, but normally the bites are treatable with an antidote.
The problem, say South African veterinarians, is that they currently have virtually no vials of the antiserum left.
"We've been out of antivenom for quite some months now," said Dean de Kock, a vet at the Valley Farm Animal Hospital in Pretoria, where Zarza was treated but eventually died.
Vets and snake experts say the shortage started getting serious towards the end of last year -- though the authorities are denying there is a problem.
"Snakebite antivenom is available in the country," the National Health Laboratory Service (NHLS), a government body in charge of antidote production, told AFP.
Experts in the field disagree.
- A 'countrywide shortage' -
In April, a group of snakebite treatment specialists pleaded with the health minister over what they described as "a major health risk".
While the supply problems may be easing in some quarters, vets say they are still struggling.
Hospitals treating humans get priority when any new doses come available, said Johan Marais, a herpetologist -- specialist in reptiles and amphibians -- who heads the African Snakebite Institute.
"At the moment, if you're a veterinarian, you cannot get antivenom," said Marais, 65.
Speaking from his headquarters in Pretoria, he casually handled a black mamba during his conversation with AFP.
He said he receives up to a dozen calls a day from desperate animal doctors and dog owners looking for antidotes.
"If your dog gets a serious snakebite today, there's a likelihood it's going to die," Marais said.
Alan Kloeck, of the South African Veterinary Association, confirmed Marais's remarks, describing a "countrywide shortage" with vets unable to get their hands on the antiserum they needed.
- Horse blood, spitting cobras -
South Africa is home to about 160 species of snakes, many of them poisonous.
South African Vaccine Producers -- a NHLS subsidiary and the only antivenom maker in the country -- produces two antidotes.
One can treat bites from 10 snakes including the cape cobra, the puff adder and the green mamba, while another is for relatively rare boomslang bites.
Making the antiserums is a laborious process, said Mike Perry of African Reptiles and Venom, a venom-extraction firm in Centurion, outside Johannesburg, that houses around 900 snakes in small glass cages.
He said his team forces the hissing reptiles to spit out their poison by forcing them to bite a glass jar.
Small quantities of the toxins are then injected into horses, which over time develop immunity.
Their plasma is then harvested and processed to make the serum.
But that process requires constant refrigeration, and the production backlog has been blamed in large part on South Africa's energy crisis, which has caused repeated power blackouts.
In April, NHLS said it required "a consistent and dependable power supply" to produce antivenom.
The continuous switchover to generators during outages interrupted production and affected stockpiles, it said, forcing it to invest in backup power systems and renewable energy.
- 'Last vial' -
Last week, NHLS said it had increased manufacturing in recent months.
Since January, it said, it had delivered antivenom to more than 230 institutions, including hospitals and veterinary clinics, fulfilling all orders apart from "a small backlog" affecting a provincial depot.
But de Kock, whose veterinary practice is in a different province, has not received any shipments since December. For a while, they were using expired doses from other hospitals, but these too have dried up.
"We have used the last vial on Sunday evening," he said last week.
Over the past three months, the hospital treated 25 dogs for snakebites.
Of the 16 who could get expired antivenom, only one did not survive, while six of the nine who could not get doses died.
Zarza was among them, dying in May after a two-day struggle on a ventilator.
"It's tough," said de Kock, 53. "You're doing everything you can but the vital thing that you actually need is the antivenom, and you don't have that".
His hope was that the austral winter months, when snakes are less active, would bring some relief.
J.AbuHassan--SF-PST